We examine the role of different network capabilities of companies that influence the formation of r&d partnerships in pharmaceutical biotechnology. Strategic network capabilities, specifically centrality-based capabilities and the efficiency with which companies choose their partners, are found to facilitate the formation of new partnerships. Unlike general experience with partnering, these strategic network capabilities play a crucial role in enabling companies to continue to interact with other companies through partnerships in a complex network setting.
Hagedoorn, J., Roijakkers, A. H. W. M., & van Kranenburg, H. L. (2006). Inter-firm R&D networks: the importance of strategic network capabilities for high-tech partnership formation. British Journal of Management, 17, 39-53. https://doi.org/10.1111/j.1467-8551.2005.00474.x